AIM: This study aims to describe the feasibility and safety of direct occluded vessel puncture as a new access site for complex peripheral artery occlusive disease. METHODS: Eleven consecutive patients with symptomatic peripheral artery disease underwent endovascular therapy using the direct occluded vessel puncture technique. The occluded vessel was punctured using a dedicated 20 G needle and the Hi-Torque Command 18 ST guidewire under duplex echo or fluoroscopic guidance, and a 6 Fr sheath was then inserted. Hemostasis was achieved with the Exoseal® Vascular Closure Device. RESULTS: Direct occluded vessel puncture was achieved in 10 of 11 cases (90.9%), and procedural success was achieved in all cases. There were no in-hospital deaths or any complications, including bleeding, pseudoaneurysms, thrombosis, or surgical conversion. CONCLUSION: The direct occluded vessel puncture technique using a 20 G needle and the Hi-Torque Command 18 ST is feasible and safe. This technique may also be used as an alternative option when there are no appropriate approach sites.
AIM: This study aims to describe the feasibility and safety of direct occluded vessel puncture as a new access site for complex peripheral artery occlusive disease. METHODS: Eleven consecutive patients with symptomatic peripheral artery disease underwent endovascular therapy using the direct occluded vessel puncture technique. The occluded vessel was punctured using a dedicated 20 G needle and the Hi-Torque Command 18 ST guidewire under duplex echo or fluoroscopic guidance, and a 6 Fr sheath was then inserted. Hemostasis was achieved with the Exoseal® Vascular Closure Device. RESULTS: Direct occluded vessel puncture was achieved in 10 of 11 cases (90.9%), and procedural success was achieved in all cases. There were no in-hospital deaths or any complications, including bleeding, pseudoaneurysms, thrombosis, or surgical conversion. CONCLUSION: The direct occluded vessel puncture technique using a 20 G needle and the Hi-Torque Command 18 ST is feasible and safe. This technique may also be used as an alternative option when there are no appropriate approach sites.
Authors: Andrej Schmidt; Yvonne Bausback; Michael Piorkowski; Martin Werner; Sven Bräunlich; Matthias Ulrich; Ramon Varcoe; Josef Friedenberger; Johannes Schuster; Spiridon Botsios; Dierk Scheinert Journal: J Endovasc Ther Date: 2012-02 Impact factor: 3.487
Authors: Uri Rimon; Boris Khaitovich; Dmitry Yakubovich; Paul Bensaid; Gil Golan; Daniel Silverberg Journal: Cardiovasc Intervent Radiol Date: 2014-09-11 Impact factor: 2.740
Authors: Daniel Maxien; Barbara Behrends; Karla M Eberhardt; Tobias Saam; Sven F Thieme; Maximilian F Reiser; Marcus Treitl Journal: J Endovasc Ther Date: 2012-12 Impact factor: 3.487
Authors: Craig M Walker; Jihad Mustapha; Thomas Zeller; Andrej Schmidt; Miguel Montero-Baker; Aravinda Nanjundappa; Marco Manzi; Luis Mariano Palena; Nelson Bernardo; Yazan Khatib; Robert Beasley; Luis Leon; Fadi A Saab; Adam R Shields; George L Adams Journal: J Endovasc Ther Date: 2016-08-24 Impact factor: 3.487